- Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial2023 | Third Faculty of Medicine
- Telomerase activity increases in progression of myelodysplastic syndromes and is common feature of untreated acute myeloid leukemia associated with a portion of blasts in analyzed tissuePublication without faculty affiliation
- Report of University Hospital Hradec Králové to the clinical trial protocol No: 97280Publication without faculty affiliation